Try our beta test site

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 7, 2017 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT00923013
First received: June 17, 2009
Last updated: February 10, 2017
Last verified: February 7, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 31, 2018
  Estimated Primary Completion Date: December 31, 2018 (Final data collection date for primary outcome measure)